Return to Article Details
A Study on the Efficacy of 24 Weeks of Sofosbuvir, Daclatasvir with Ribaravin in the Treatment of Chronic Hepatitis C Patients with Cirrhosis, Genotype 1 and 3.
Download
Download PDF